CoChat

Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial

Open access

The DOI matches its Crossref record; 63 of the 65 references it cites were found in a registry or an index; 10 of the 41 sources its claims cite were checked for support.

Abstract

This randomized, placebo-controlled, crossover, and double-blind trial aimed to examine the possible effects of four weeks L-theanine administration on stress-related symptoms and cognitive functions in healthy adults. Participants were 30 individuals (nine men and 21 women; age: 48.3 ± 11.9 years) who had no major psychiatric illness. L-theanine (200 mg/day) or placebo tablets were randomly and blindly assigned for four-week administration. For stress-related symptoms, Self-rating Depression Scale, State-Trait Anxiety Inventory-trait, and Pittsburgh Sleep Quality Index (PSQI) scores decreased after L-theanine administration (p = 0.019, 0.006, and 0.013, respectively). The PSQI subscale scores for sleep latency, sleep disturbance, and use of sleep medication reduced after L-theanine administration, compared to the placebo administration (all p < 0.05). For cognitive functions, verbal fluency and executive function scores improved after L-theanine administration (p = 0.001 and 0.031, respectively). Stratified analyses revealed that scores for verbal fluency (p = 0.002), especially letter fluency (p = 0.002), increased after L-theanine administration, compared to the placebo administration, in individuals who were sub-grouped into the lower half by the median split based on the mean pretreatment scores. Our findings suggest that L-theanine has the potential to promote mental health in the general population with stress-related ailments and cognitive impairments.

Overview

CoChat Summary

TL;DR

In a randomized, placebo-controlled, double-blind crossover trial of 30 healthy adults, four weeks of L-theanine (200 mg/day) improved some stress-related symptom scores and cognitive scores, especially verbal fluency in participants with lower baseline performance. L-theanine was safe and well tolerated, but effects versus placebo were limited to certain PSQI subscales and verbal fluency.

Key findings

  • SDS, STAI-trait, and PSQI scores decreased after L-theanine administration (p = 0.019, 0.006, and 0.013, respectively); PSQI sleep latency and daytime dysfunction also improved (p = 0.036 and 0.022), with no significant changes after placebo.
  • Compared with placebo, reductions were greater for PSQI sleep latency, sleep disturbance, and use of sleep medication (p = 0.0499, 0.046, and 0.047), while SDS and PSQI changes showed non-significant trends (p = 0.084 and 0.073).
  • BACS verbal fluency and executive function improved after L-theanine (p = 0.001 and 0.031); in the lower half by median split, verbal fluency and letter fluency improved more than placebo (both p = 0.002), with executive function trending (p = 0.062).
  • Serum L-theanine increased after L-theanine (p = 0.002) and differed from placebo (p = 0.028); no other biochemical indices changed significantly, and no adverse events or dropouts occurred.

Methods

  • Thirty adults (9 men, 21 women; mean age 48.3 ± 11.9 years, range 20–69) without major psychiatric illness were randomized to 200 mg/day L-theanine or placebo before sleep for four weeks, then crossed over after a two-week washout.
  • Assessments at baseline and weeks 4, 6, and 10 included SDS, STAI, PSQI, Trail-Making Test, Stroop test, BACS, and blood/saliva laboratory measures including serum L-theanine.
  • Within-condition changes used Wilcoxon signed-rank tests; between-condition changes used Mann-Whitney U tests with r effect sizes; BACS scores were stratified by median split of mean pretreatment scores; two-tailed p < 0.05 was significant.

Limitations

  • The paper states: real-world setting with unaccounted biases (tea consumption, medicine, diet, nutrients, work); only about 20% of symptom and cognitive measures changed significantly versus placebo, suggesting limited daily-function effects; participants had no psychiatric disorders, so effects may be inconspicuous; small n = 30 may be insufficient and subject to type II errors; wider age range and both sexes were included due to lack of solid information on specific subgroups.
  • The paper also notes that compliance was checked only verbally and usual green tea or other L-theanine-containing beverage intake was not tracked.
  • Evident from the text: no correction for multiple comparisons is reported, and Trail Making Test A and B improved significantly after placebo (p = 0.042 and 0.038), which complicates attribution of cognitive changes.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/nu11102362

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Stress-related symptom scores after 4 weeks L-theanine or placebo administration. The Wilcoxon signed-rank test revealed that the Self-rating Depression Scale, State-Trait Anxiety Inventory-trait, and Pittsburgh Sleep Quality Index scores were significantly decreased in the L-theanine administration (n = 30), while there was no significant change in the placebo administration (n = 30). * p < 0.05, ** p < 0.01. N.S., not significant.
Figure 1 Stress-related symptom scores after 4 weeks L-theanine or placebo administration. The Wilcoxon signed-rank test revealed that the Self-rating Depression Scale, State-Trait Anxiety Inventory-trait, and Pittsburgh Sleep Quality Index scores were significantly decreased in the L-theanine administration (n = 30), while there was no significant change in the placebo administration (n = 30). * p < 0.05, ** p < 0.01. N.S., not significant.CC BY · PubMed Central
Figure 2 Cognitive function scores after 4 weeks L-theanine or placebo administration. The Wilcoxon signed-rank test revealed that the Brief Assessment of Cognition in Schizophrenia (BACS) verbal fluency and executive function scores were significantly decreased in the L-theanine administration (n = 30), while there was no significant change in the placebo administration (n = 30). * p < 0.05, ** p < 0.01. N.S.: Not significant.
Figure 2 Cognitive function scores after 4 weeks L-theanine or placebo administration. The Wilcoxon signed-rank test revealed that the Brief Assessment of Cognition in Schizophrenia (BACS) verbal fluency and executive function scores were significantly decreased in the L-theanine administration (n = 30), while there was no significant change in the placebo administration (n = 30). * p < 0.05, ** p < 0.01. N.S.: Not significant.CC BY · PubMed Central

Verification

Claims the paper makes

8 Valid · 1 Not valid · 4 Not checked · 58 Own results and interpretations

41 more claims

Create a free account to see all 71 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 15
  • Probably not a substantial claim. 13

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 63 references

Research works printed but not linked: 1

  1. Spielberg, C.D. (1970). STAI Manual, Consulting Psychologists Press.

Cited by

See all 170

Metadata

Authors
Hidese, S., Ogawa, S., Ota, M., Ishida, I., Yasukawa, Z., Ozeki, M., & Kunugi, H.
Affiliations
  • National Center of Neurology and Psychiatry (JP)
  • Taiyo Kagaku Co., Ltd. (Japan) (JP)
Corresponding author
Kunugi, Hiroshi
Venue
Nutrients
Publisher
MDPI AG
Published
2019-10-03
Volume
11
Issue
10
Pages
2362
ISSN
2072-6643 (ISSN-L)
OpenAlex
W2977908783
Cited by
170
References
65
Citations by year
2026: 32 · 2025: 38 · 2024: 34 · 2023: 23 · 2022: 18 · 2021: 17 · 2020: 8
FWCI
3.44
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
Funders
Funding received from Taiyo Kagaku Co., Ltd., Mie, Japan. (None)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Keywords
theanine, stress-related symptoms, cognitive function, depression, anxiety, sleep quality, sleep latency, sleep disorders, sleep medication use, verbal fluency, phonemic fluency, executive function, healthy adults, mental health
MeSH terms
Adult, Anxiety, Cognition, Depression, Double-Blind Method, Female, Glutamates, Humans, Male, Middle Aged, Placebos, Sleep Wake Disorders, Stress, Psychological, Body Mass Index, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial. https://app.cochat.ai/papers/10.3390/nu11102362
The paper
Hidese, S., Ogawa, S., Ota, M., Ishida, I., Yasukawa, Z., Ozeki, M., & Kunugi, H. (2019). Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial. Nutrients. https://doi.org/10.3390/nu11102362

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.